Actinium Pharmaceuticals, Inc. (ATNM)

1.36 0.00 (0.00%) USD  |  NYAM  |  Jan 02, 16:00
1.36 0.00 (0.00%) After-Hours: 19:35
More

Actinium Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ATNM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Arcus Biosciences, Inc. Upgrade
Apyx Medical Corp. Upgrade
AbbVie, Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade